The Cancer Prevention Manual

Simple rules to reduce the risks
2. Auflage 2015
ISBN: 978-0-19-871985-4
Verlag: Oxford University Press

Buch, Englisch, 102 Seiten, Print PDF, Format (B × H): 129 mm x 197 mm, Gewicht: 124 g

Stories in the media about the cancer-causing risks present in everyday life can cause alarm and confusion, and make it difficult to know how to alter one's lifestyle. The Cancer Prevention Manual, Second Edition, is a handy guide to all key issues in cancer prevention, presenting medical and scientific information in a plain, accessible style. Written by authors with distinguished careers studying the illness, and based on a solid scientific grounding, this book provides the facts about how our lifestyles pose cancer risks, and what we can do to change them.

Autoren/Hrsg.

Olver, Ian

Stephens, Fred

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Public Health, Gesundheitsmanagement, Gesundheitsökonomie, Gesundheitspolitik
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Medizin, Gesundheit: Sachbuch, Ratgeber
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung

Inhaltsverzeichnis

- 1: What is cancer?

- 2: What causes cancer?

- 3: Lifestyle changes that prevent cancer

- 4: Risk factors and the prevention of specific cancers

- 5: Research into cancer risk

- Bibliography

- Index

Über Autor(innen)

Ian Olver is Professor of Translational Cancer Research and Director of the Sansom Institute for Health Research at the University of South Australia.

Fred Stephens is Emeritus Professor and Former Head of the Department of Surgery at The University of Sydney. He is also Consultant Emeritus in Surgical Oncology at Sydney Hospital and the Royal Prince Alfred Hospital, Sydney Australia. He writes from a lifetime of experience in cancer research and management, including pioneering surgical regimens for certain difficult locally advanced cancers.